Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05323175 · ClinicalTrials.gov registry record · Phase 4
Erector Spinae Plane (ESP) Block for Renal Colic
A Phase 4 study of Renal Colic, sponsored by Stony Brook University.
- Active
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05323175: Active Phase 4 study of Renal Colic, sponsored by Stony Brook University.
NCT05323175 is a Phase 4 study of Renal Colic that is active but no longer recruiting, run by Stony Brook University. The registered enrollment target is 24 participants, below the 92-participant average among 3 other Renal Colic trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05323175, a Phase 4 study of Renal Colic, is active but no longer recruiting, sponsored by Stony Brook University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparing standard of care to erector spinae plane block for acute renal colic pain.
Primary Outcome
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"
Conditions Studied
Interventions
- DRUG Ropivacaine injection
- OTHER Standard of care medications
Study Locations (1)
New York
- StonyBrook University Hospital - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2025-06-01 |
| Phase | Phase 4 |
What the registry record for NCT05323175 still lists
NCT05323175 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 92-participant average among 3 other Renal Colic trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Renal Colic appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine injection is the first listed.
NCT05323175 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05323175 about?
NCT05323175 is a clinical study titled "Erector Spinae Plane (ESP) Block for Renal Colic". Comparing standard of care to erector spinae plane block for acute renal colic pain.
What is the current status of trial NCT05323175?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2022-04-25. Estimated completion is 2025-06-01.
What conditions does trial NCT05323175 study?
This clinical trial studies the following conditions: Renal Colic.
What interventions are being tested in trial NCT05323175?
The interventions under investigation include: Ropivacaine injection (DRUG), Standard of care medications (OTHER).
Who is sponsoring clinical trial NCT05323175?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05323175 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Colic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
The Use of AR / VR in Patients Presenting to the ED With Renal Colic
RECRUITING · NA
-
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI